John Libbey Eurotext




(Neo)adjuvant chemotherapy of resected colorectal cancer liver metastases
Hépato-Gastro. Volume 19, Number 2, 77-83, Février 2012, Mini-revue
Résumé Texte intégral
Author(s) : Astrid Lièvre, Frédérique Peschaud, Emmanuel Mitry
Summary : Colorectal cancer (CRC) liver metastases (LM) are very common but only 20 to 30% of them will be resectable with, in this case, prolonged survival and a possibility to be cured. Their surgical resection should be systematically discussed in multidisciplinary meeting and be re-evaluated when a response to induction chemotherapy has been observed for LM that were not initially resectable. Recurrence, especially in the liver, are common. Perioperative chemotherapy with FOLFOX reduces the risk of recurrence of resectable LM but expose to the risk of missing metastases that can make their resection a problem.
Keywords : colorectal cancer, liver metastases, surgery, chemotherapy

(Neo)adjuvant chemotherapy of resected colorectal cancer liver metastases